The Race for a Breakthrough: Pfizer's Bold Bet on Battling Obesity, Outmaneuvering Novo Nordisk

The Billion-Dollar Battle for the Future of Weight Loss: Pfizer Jumps into the Ring

The Weight of Ambition: Pfizer’s Bold Move into the Obesity Race

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars

The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race

The Pharmaceutical Thunderdome: Pfizer's Bold Play in the Billion-Dollar Battle for Obesity Drugs

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great Weigh-In: Pfizer's Bold Bet in the Billion-Dollar Battle for Obesity Drug Dominance

The Great Weight-Loss Race: Pfizer's Billion-Dollar Gambit to Conquer Obesity

A Tsunami of Pills: Eli Lilly's Grand Plan to Conquer the Weight Loss Market

Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment

Novo Nordisk's Strategic Overhaul: 9,000 Job Cuts to Propel Future Dominance

Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed